GlassScriptPhysician profile
Frine T Roca
NPI 1265487185
$3,400.94
in general payments reported to CMS, 2019-2025
15 companies · $811 in 2025
The $811 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $277 · 2021: $277 · 2022: $302 · 2023: $442 · 2024: $892 · 2025: $811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,144.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $2,041.34 | 2021-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $382.45 | 2019-2024 | Jornay Pm |
| Corium, LLC | $236.50 | 2022-2025 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $178.05 | 2019-2022 | |
| Neos Therapeutics, LP | $150.38 | 2019-2022 | |
| Adlon Therapeutics L.P. | $97.17 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $75.64 | 2025 | Jornay Pm |
| Pfizer INC. | $54.45 | 2020-2024 | |
| Shire North American Group INC | $47.41 | 2019 | |
| Tris Pharma INC | $38.05 | 2020 | |
| Arbor Pharmaceuticals, INC. | $31.24 | 2019 | |
| Phadia US INC. | $24.21 | 2019 | |
| Abbott Laboratories | $16.28 | 2024 | Proclaim |
| Genentech USA, INC. | $15.73 | 2020 | |
| Sanofi Pasteur INC. | $12.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frine Roca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.